The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference

被引:98
作者
Bergenstal, RM
Gavin, JR
机构
[1] Int Diabet Ctr, Minneapolis, MN 55416 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA
关键词
consensus conference; glycemic control; glycosylated hemoglobin; self-monitoring of blood glucose; glucose monitoring; glucose profile;
D O I
10.1016/j.amjmed.2005.07.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Self-monitoring of blood glucose (SMBG) is an underutilized but integral part of disease management for patients with both type I and type 2 diabetes. Guidelines on the recommended frequency and timing of SMBG vary among international diabetes associations, and patients are often unaware of actions they should take in response to SMBG results. In response to this, a global consensus conference of recognized diabetes experts convened to clarify the role of SMBG as a tool to help optimize glycemic control (e.g., complementing information provided by hemoglobin A(1c), detecting postprandial excursions, identifying glucose patterns, and providing patients feedback on lifestyle and medications) while minimizing hypoglycemia and maintaining quality of life. The consensus panel also sought to reinforce the importance of appropriate and systematic patient and provider response to the collected SMBG data. A set of 16 consensus statements was approved by the panel. This article presents the 16 statements together with some brief rationale for their inclusion. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1S / 6S
页数:6
相关论文
共 52 条
  • [11] Inside guidelines - Comparative analysis of recommendations and evidence in diabetes guide
    Burgers, JS
    Bailey, JV
    Klazinga, NS
    Van der Bij, AK
    Grol, R
    Feder, G
    [J]. DIABETES CARE, 2002, 25 (11) : 1933 - 1939
  • [12] *CAN DIAB ASS CLIN, 2003, CAN J DIABETES S2, V27, pS1
  • [13] The relationship between glucose and incident cardiovascular events
    Coutinho, M
    Gerstein, HC
    Wang, Y
    Yusuf, S
    [J]. DIABETES CARE, 1999, 22 (02) : 233 - 240
  • [14] Cunningham MA, 2001, NURS CLIN N AM, V36, P361
  • [15] Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894
  • [16] Model of Complications of NIDDM .2. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia
    Eastman, RC
    Javitt, JC
    Herman, WH
    Dasbach, EJ
    CopleyMerriman, C
    Maier, W
    Dong, F
    Manninen, D
    Zbrozek, AS
    Kotsanos, J
    Garfield, SA
    Harris, M
    [J]. DIABETES CARE, 1997, 20 (05) : 735 - 744
  • [17] Gatling W, 1998, DIABETIC MED, V15, P1015, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1015::AID-DIA719>3.0.CO
  • [18] 2-K
  • [19] Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563
  • [20] Glycosylated hemoglobin: Finally ready for prime time as a cardiovascular risk factor
    Gerstein, HC
    [J]. ANNALS OF INTERNAL MEDICINE, 2004, 141 (06) : 475 - 476